All Stories

  1. Vitamin D as a Shield against Aging
  2. Gluten-Free Diet and Metabolic Syndrome: Could Be a Not Benevolent Encounter?
  3. New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food
  4. Bone fragility during the COVID-19 pandemic: the role of macro- and micronutrients
  5. Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on ‘Diagnosis, risk stratification, and continuity of care of fragility fractures’ based on a systematic literature review
  6. Nutritional and physical activity issues in frailty syndrome during the COVID-19 pandemic
  7. Which physical activity in patients affected by hypoparathyroidism? A review of the literature and practical recommendations
  8. Environmental Contaminants Acting as Endocrine Disruptors Modulate Atherogenic Processes: New Risk Factors for Cardiovascular Diseases in Women?
  9. Nutrition and Physical Activity-Induced Changes in Gut Microbiota: Possible Implications for Human Health and Athletic Performance
  10. Environmental Contaminants Acting as Endocrine Disruptors Modulate Atherogenic Processes: New Risk Factors for Cardiovascular Diseases in Women?
  11. Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study
  12. The endocrine disruptor cadmium: a new player in the pathophysiology of metabolic diseases
  13. Phosphodiesterase Type-5 Inhibitor Tadalafil Modulates Steroid Hormones Signaling in a Prostate Cancer Cell Line
  14. Dietary Calcium Intake in a Cohort of Individuals Evaluated for Low Bone Mineral Density: a Multicenter Italian Study
  15. MicroRNA Modulation by Dietary Supplements in Obesity
  16. Tissue and circulating microRNAs as biomarkers of response to obesity treatment strategies
  17. Circulating Long Non-Coding RNA GAS5 Is Overexpressed in Serum from Osteoporotic Patients and Is Associated with Increased Risk of Bone Fragility
  18. Can Haematological and Hormonal Biomarkers Predict Fitness Parameters in Youth Soccer Players? A Pilot Study
  19. Dietary Calcium Intake in a Cohort of Individuals Evaluated for Low Bone Mineral Density: A Multicentre Italian Study
  20. <p>Multifactorial Assessment of Risk of Falling in 753 Post-Menopausal Women: A Multicenter Cross-Sectional Study by the Italian Group for the Study of Metabolic Bone Diseases</p>
  21. Do Dietary Supplements and Nutraceuticals Have Effects on Dental Implant Osseointegration? A Scoping Review
  22. Effects of Acute Whole-Body Vibration Practice on Maximal Fat Oxidation in Adult Obese Males: A Pilot Study
  23. Effect of pre-season training phase on anthropometric, hormonal and fitness parameters in young soccer players
  24. Role of vitamin K2 in bone metabolism: a point of view and a short reappraisal of the literature
  25. Epigenetic Modifications Induced by Nutrients in Early Life Phases: Gender Differences in Metabolic Alteration in Adulthood
  26. Energy Balance and Active Lifestyle: Potential Mediators of Health and Quality of Life Perception in Aging
  27. Role of Hypovitaminosis D in the Pathogenesis of Obesity-Induced Insulin Resistance
  28. Characterization of the Effects of a Six-Month Dancing as Approach for Successful Aging
  29. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
  30. Retrospective evaluation of persistence in osteoporosis therapy with oral bisphosphonates in Italy: the TOBI study
  31. Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly
  32. Relationship between individual ventilatory threshold and maximal fat oxidation (MFO) over different obesity classes in women
  33. Effects of body weight loss program on parameters of muscle performance in female obese adults
  34. Response to: Comment #2 on “Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects”
  35. Correction to: Cadmium exposure alters steroid receptors and proinflammatory cytokine levels in endothelial cells in vitro: a potential mechanism of endocrine disruptor atherogenic effect
  36. Effects of essential amino acid supplementation and rehabilitation on functioning in hip fracture patients: a pilot randomized controlled trial
  37. Cadmium exposure alters steroid receptors and proinflammatory cytokine levels in endothelial cells in vitro: a potential mechanism of endocrine disruptor atherogenic effect
  38. Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO
  39. Guidelines for the management of osteoporosis and fragility fractures
  40. Prediction equation to estimate heart rate at individual ventilatory threshold in female and male obese adults
  41. HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy
  42. Functional determinants of dietary intake in community-dwelling older adults: a DEDIPAC (DEterminants of DIet and Physical ACtivity) systematic literature review
  43. Multidisciplinary Approach to Osteoporosis
  44. Effects of an individualized home-based unsupervised aerobic training on body composition and physiological parameters in obese adults are independent of gender
  45. The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism
  46. Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy
  47. Alterations of functional connectivity of the motor cortex in Fabry disease
  48. Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis
  49. Insulin growth factor-1 correlates with higher bone mineral density and lower inflammation status in obese adult subjects
  50. Potential role for the VDR agonist elocalcitol in metabolic control: Evidences in human skeletal muscle cells
  51. Tadalafil improves lean mass and endothelial function in nonobese men with mild ED/LUTS: in vivo and in vitro characterization
  52. Response to: Comment on “Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects”
  53. Validation of the Italian version of the Laval questionnaire: health-related quality of life in subjects with obesity
  54. Physical activity and hypocaloric diet recovers osteoblasts homeostasis in women affected by abdominal obesity
  55. Disability, Physical Inactivity, and Impaired Health-Related Quality of Life Are Not Different in Metabolically Healthy vs. Unhealthy Obese Subjects
  56. Using concept mapping in the development of the EU-PAD framework (EUropean-Physical Activity Determinants across the life course): a DEDIPAC-study
  57. Are dietary supplements and nutraceuticals effective for musculoskeletal health and cognitive function? A scoping review
  58. Critical review of the equations predicting 6-minute walking distance in obese subjects
  59. Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy
  60. Effects of combined physical education and nutritional programs on schoolchildren’s healthy habits
  61. Reduced sleep duration affects body composition, dietary intake and quality of life in obese subjects
  62. Assessment of trabecular bone score (TBS) in overweight/obese men: effect of metabolic and anthropometric factors
  63. The pathophysiological basis of bone tissue alterations associated with eating disorders
  64. Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects
  65. The obesity of bone
  66. The endocrine disruptor cadmium alters human osteoblast-like Saos-2 cells homeostasis in vitro by alteration of Wnt/β-catenin pathway and activation of caspases
  67. Prevalent fragility fractures as risk factor for skeletal muscle function deficit and dysmobility syndrome in post-menopausal women
  68. Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model
  69. Osso e infiammazione
  70. Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism
  71. Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
  72. Multidisciplinary Approach to Obesity
  73. Effects of Aerobic Exercise Based upon Heart Rate at Aerobic Threshold in Obese Elderly Subjects with Type 2 Diabetes
  74. P148: La fonction physique, le niveau d’activité physique et d’autonomie chez des femmes obèses et sarcopéniques pré-gériatriques
  75. Lean mass in obese adult subjects correlates with higher levels of vitamin D, insulin sensitivity and lower inflammation
  76. Obesity and Osteoporosis
  77. Sarcopenic Obesity
  78. Interdisciplinary Approach to Obesity
  79. Ovarian Function and Obesity: PCOS, Menopause
  80. Age-associated (cardio)metabolic diseases and cross-talk between adipose tissue and skeleton: endocrine aspects
  81. P354: Obesity: body composition and functional parameters
  82. The environmental pollutant cadmium induces homeostasis alteration in muscle cells in vitro
  83. Vγ9 Vδ2 T lymphocytes activation as a novel approach to test efficacy of different bisphosphonates
  84. Psoriasis and bone mineral density: Implications for long‐term patients
  85. Treatment of body composition changes in obese and overweight older adults: insight into the phenotype of sarcopenic obesity
  86. La distalizzazione ottenuta con il pendulum di Hilgers: revisione della letteratura
  87. Analysis of human alveolar osteoblast behavior on a nano-hydroxyapatite substrate: an in vitro study
  88. Obesity treatment: results after 4 years of a Nutritional and Psycho-Physical Rehabilitation Program in an outpatient setting
  89. Habitual fish intake and clinically silent carotid atherosclerosis
  90. Adipose, bone and muscle tissues as new endocrine organs: role of reciprocal regulation for osteoporosis and obesity development
  91. Abdominal Fat and Sarcopenia in Women Significantly Alter Osteoblasts HomeostasisIn Vitroby a WNT/β-Catenin Dependent Mechanism
  92. Health-Related Quality of Life and Quality of Sexual Life in Obese Subjects
  93. Sarcopenic Obesity: Correlation with Clinical, Functional, and Psychological Status in a Rehabilitation Setting
  94. Nutrition and Growth
  95. Arterial aneurysms: autosomal dominant polycystic kidney disease, Marfan syndrome or both?
  96. Skeletal alterations in women affected by obesity
  97. New therapeutical horizons in the management of postmenopausal osteoporosis
  98. Body composition in sarcopenic obesity: systematic review of the literature
  99. Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study
  100. Physical exercise intensity prescription to improve health and fitness in overweight and obese subjects: A review of the literature
  101. Trunk Fat Negatively Influences Skeletal and Testicular Functions in Obese Men: Clinical Implications for the Aging Male
  102. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study
  103. Concerns About Serum Androgens Monitoring During Testosterone Replacement Treatments in Hypogonadal Male Athletes: A Pilot Study
  104. Is obesity in women protective against osteoporosis?
  105. Guidelines for the diagnosis, prevention and treatment of osteoporosis
  106. Evaluation of adherence and persistence to teriparatide treatment in patients affected by severe osteoporosis: A multicenter observational real life study
  107. Effects of an Upper Body High Intensity Interval Training on Body Composition
  108. Differential characteristics of bone quality and bone turnover biochemical markers in patients with hip Fragility Fractures and Hip Osteoarthritis: results of a clinical pilot study
  109. Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro
  110. The Role of Steroids in Endothelial Function in the Aging Male
  111. Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index
  112. Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors
  113. The Role of Steroids in Endothelial Function in the Ageing Male
  114. Approach in glucocorticoid-induced osteoporosis prevention: The EGEO study preliminary data
  115. Management of glucocorticoids-induced osteoporosis: role of teriparatide
  116. Impairment of diastolic function in adult patients affected by osteogenesis imperfecta clinically asymptomatic for cardiac disease: Casuality or causality?
  117. SERMs
  118. Characterization of bone mineral density in male-to-female transsexuals receiving treatment for reassignment surgery: 15 years of follow-up
  119. A New Heterozygous Mutation (R714C) of the Osteopetrosis Gene, Pleckstrin Homolog Domain Containing Family M (With Run Domain) Member 1 (PLEKHM1), Impairs Vesicular Acidification and Increases TRACP Secretion in Osteoclasts
  120. Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment
  121. The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
  122. Effect of titanium carbide coating on the osseointegration response in vitro and in vivo
  123. Cadmium induces mitogenic signaling in breast cancer cell by an ERα-dependent mechanism
  124. Modulation of human estrogen receptor α F promoter by a protein kinase C/c-Src-dependent mechanism in osteoblast-like cells
  125. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment
  126. Raloxifene Modulates Interleukin-6 and Tumor Necrosis Factor-α Synthesisin Vivo: Results from a Pilot Clinical Study
  127. Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years' follow-up
  128. In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells
  129. Imbalance of Osteoclastogenesis-Regulating Factors in Patients With Celiac Disease
  130. Interaction of estrogen receptor α with protein kinase C α and c-Src in osteoblasts during differentiation
  131. Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway
  132. Type II Benign Osteopetrosis (Albers-Schönberg Disease) Caused by a Novel Mutation in CLCN7 Presenting with Unusual Clinical Manifestations
  133. Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro
  134. Isoflavones and skeletal health: are these molecules ready for clinical application?
  135. Estrogens and Estrogen Receptors: New Actors in the Plot of Transcriptional Regulation of Genomic Responses
  136. Genotype-Phenotype Relationship in Human ATP6i-Dependent Autosomal Recessive Osteopetrosis
  137. The Role of the AlphaVbeta3 Integrin in the Development of Osteolytic Bone Metastases: A Pharmacological Target for Alternative Therapy?
  138. The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro
  139. Characterization of the osteoblast‐like cell phenotype under microgravity conditions in the NASA‐approved rotating wall vessel bioreactor (RWV)
  140. Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved rotating wall vessel bioreactor (RWV)
  141. Apparent Cure of a Newborn with Malignant Osteopetrosis Using Prednisone Therapy
  142. Reduced Growth and Skeletal Changes in Zinc-Deficient Growing Rats Are Due to Impaired Growth Plate Activity and Inanition
  143. Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines
  144. Decreased C-Src Expression Enhances Osteoblast Differentiation and Bone Formation
  145. Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood
  146. Mechanisms of Osteoclast Dysfunction in Human Osteopetrosis: Abnormal Osteoclastogenesis and Lack of Osteoclast-Specific Adhesion Structures
  147. Osteoclast Isolation: New Developments and Methods
  148. Association of Intermediate Osteopetrosis with Poikiloderma
  149. Decreased Proliferation and Altered Differentiation in Osteoblasts from Genetically and Clinically Distinct Craniosynostotic Disorders
  150. A Novel Calcium Sensor Stimulating Inositol Phosphate Formation and [Ca2+]i Signaling Expressed by GCT23 Osteoclast‐Like Cells
  151. Modulation of Estrogen Receptor Levels in Mouse Uterus by Protein Kinase C Isoenzymes1
  152. Modulation of Estrogen Receptor Levels in Mouse Uterus by Protein Kinase C Isoenzymes
  153. Phospholipase D- and Protein Kinase C Isoenzyme-Dependent Signal Transduction Pathways Activated by the Calcitonin Receptor1
  154. Protein Kinase C Modulates Estrogen Receptors in Differentiated Osteoblastic Cells In Vitro
  155. Colony Stimulating Factor-1–Induced Osteoclast Spreading Depends on Substrate and Requires the Vitronectin Receptor and the c-src Proto-Oncogene
  156. Transforming growth factor-β enhances adhesion of melanoma cells to the endotheliumin vitro
  157. Transforming growth factor‐β enhances adhesion of melanoma cells to the endothelium in vitro
  158. Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring.
  159. Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring
  160. Alterations in estrogen levels during development affects the skeleton: use of an animal model.
  161. Alterations in Estrogen Levels during Development Affects the Skeleton: Use of an Animal Model
  162. Endogenous protein kinase-C activation in osteoblast-like cells modulates responsiveness to estrogen and estrogen receptor levels
  163. Endogenous protein kinase-C activation in osteoblast-like cells modulates responsiveness to estrogen and estrogen receptor levels.
  164. Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor
  165. Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor.
  166. Short-term exposure of developing female mice to diethylstilbestrol increases bone density in adulthood
  167. Developmental exposure to estrogens induces persistent changes in skeletal tissue.
  168. Developmental exposure to estrogens induces persistent changes in skeletal tissue
  169. Long Term Treatment with Adenosine Analogs Modifies the Responsiveness of Immature Rat Sertoli Cell in Culture*
  170. A Novel Melatonin Antagonist, N-(2,4-Dinitrophenyl)-5-Methoxytryptamine Neutralizes Some Effects of Melatonin in the Female Syrian Hamster
  171. Characterization and Function of Adenosine Receptors in the Testisa
  172. Rate of reproductive involution following either exposure to short days or daily administration of melatonin is faster in inbred than in random-bred female Syrian hamsters